The prevalence of coronary vessel wall alterations in the general population is not known. Therefore, the aim of our study was to determine the prevalence of coronary artery disease in persons in whom the underlying disease was not related to coronary artery disease and could therefore be regarded as a near normal population.
Introduction
The prevalence of coronary vessel wall alterations in the general population is unknown. This is due to the fact that coronary angiography is generally only indicated in patients with a history of coronary artery disease or with clinical symptoms typical for this disease. Nevertheless, autopsy in individuals who died of non-cardiac causes revealed a high prevalence of one-vessel disease (up to 10%) [1] . To determine the prevalence of coronary artery disease, as well as the degree and the extent of coronary lesions in a cohort of subjects, as nearly representative of the general population as we could obtain, we analysed the coronary angiograms of patients who had routinely undergone coronary angiography before radiofrequency catheter ablation of accessory pathways or atrioventricular-node modification. We also assessed the differences in risk factors in patients with and without vessel wall alterations.
Patients and methods
Patients above 40 years of age in whom radiofrequency catheter ablation of an accessory pathway or modification of the atrioventricular-node was planned, underwent coronary angiography to establish a baseline coronary profile before radiofrequency ablation, since some data had suggested that radiofrequency currents might have some effect on coronary vessels. Three hundred and thirty-one consecutive patients, 173 men and 158 women were included. Two hundred and sixtyone patients (79%), 134 men, 127 women, were free of clinical symptoms suggestive of coronary artery disease, the other group of patients (n=70, 39 men, 31 women) were symptomatic, presenting with chest pain unrelated to episodes of tachycardia.
The coronary risk profile (weight, height, systolic and diastolic blood pressure, diabetes mellitus, smoking status, lipid profile) and current medication (antiplatelet agents, beta-blockers, ACE inhibitors, nitrates, calciumchannel blockers, lipid lowering drugs) were obtained from the patients' records.
After intracoronary injection of 0·2 mg nitroglycerin in either coronary artery to reduce vasomotor tone, multiplane cine coronary angiograms were obtained using the Judkins technique, mostly via a left femoral 5 French sheath. Angiograms included at least five projections of the left and three projections of the right coronary artery tree, with at least two projections each being in a rectangular orientation.
Coronary angiograms were independently reviewed by two experienced cardiologists blinded to the patients' clinical and laboratory findings. In the presence of stenoses greater than 50% of lumen diameter, coronary angiographic findings were grouped as one-to threevessel disease. The cinefilms were then evaluated using two different score systems which describe the extent and severity of vessel wall alterations [2] [3] [4] . (a) Stenosis score: 0-32 points. The maximum diameter reduction of eight coronary segments (left main stem, left anterior descending artery, main diagonal branch, main septal branch, left circumflex artery, main marginal branch, right coronary artery, right posterior descending branch) was scored with 1 to 4 points according to a luminal narrowing of 1 to 49% (1 point), 50 to 74% (2 points), 75-99% (3 points) or total occlusion (4 points).
(b) Extent score: 0-100 points. This score was developed by Sullivan et al. [2] . According to the proportional length of each vessel segment in the coronary artery tree, segments are graded with different numbers of maximum points: 5 points for the left main stem, 20 for the left anterior descending artery, 10 for the main diagonal branch, 5 for the first septal branch, 20 for the left circumflex artery, 10 for the marginal and posterolateral vessels, 20 for the right coronary artery, and 10 for the right posterior descending branch. The number of points for each segment (irrespective of the degree of the diameter reduction) was expressed as the percentage length of visible lesions within the total segment. Occluded vessels which were filled with contrast medium by collateral flow, were evaluated according to the visible irregularities of the vessel wall. If no collateral flow existed, the mean value of all other vessel segments in this angiogram was transferred to this occluded vessel segment.
Statistical evaluation was performed using the Statistical Package for the Social Sciences (SPSS), version 6.1. Bivariate relationships of stenosis and extent scores with other variables were calculated by Pearson correlation coefficients. All P-values are two-tailed.
Results
The age distribution of the whole cohort is shown in Fig. 1 . The mean age was equal in men and women, but a higher proportion of patients symptomatic for coronary artery disease compared to asymptomatic persons was in the group aged 61 to 70 years (27·1 vs 13·8%). Table 1 presents the baseline characteristics including coronary risk factors. Prevalence of risk factors except current smoking was higher in symptomatic than in asymptomatic patients. Levels of total cholesterol and of LDL cholesterol were moderately elevated with no significant differences between male and female patients, but HDL cholesterol was markedly lower in asymptomatic men than in women (45 14 vs 60 17 mg . dl 1 ) paralleled by higher triglyceride levels in asymptomatic men than in women (161 91 vs 121 86 mg . dl 1 ). Treatment with drugs was very low in the study group with the exception of beta-blockers (40·5%) used as antiarrhythmic agents. 13·6% took antiplatelet agents, mostly in order to reduce the risk of thromboembolic events in connection with the interventional electrophysiological procedure. 6·9% were treated with ACE inhibitors, 3·3% with nitrates, 17·8% with calcium antagonists. 3·3% of the patients received lipid lowering agents.
The results of coronary angiography analysis are presented in Table 2 (a) and (b). In the majority of patients (92·7%), there was no coronary artery disease. The prevalence of coronary artery disease (=1-3-vessel disease) in the total group was 7·3%. Twelve patients had one-vessel disease, seven patients two-vessel disease and five patients (only men) had three-vessel disease. The prevalence of coronary artery disease was higher in men in comparison to women (10·4 vs 3·8%) and especially higher in symptomatic patients compared to asymptomatic patients (17·1 vs 3·8%, not shown). The mean values of the coronary scores were very low compared to the maximum values (Table 2 (b)). They were significantly higher in men than in women (P<0·001). The distribution of the extent score is shown in Fig. 2 .
In Table 3 , the baseline variables are compared between patients with at least one stenosis >50%, and to patients without significant stenoses. Patients with coronary artery disease had slightly but not significantly higher levels of total cholesterol (241 54 vs 237 41 mg . dl 1 ) and lower levels of HDL-cholesterol (43 11 vs 52 17 mg . dl 1 ). Patients without critical stenoses had very low extent scores (Fig. 3) . Scores in patients with coronary artery disease were also low, but the number of affected vessels (stenosis score) and the extension of vessel wall alterations (extent score) was 
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significantly larger in this subgroup than in patients without significant stenoses greater than 50% (P<0·001, Fig. 4) .
Regarding baseline variables and serum lipids in relation to scores, systolic and diastolic blood pressure, LDL cholesterol, and lipoprotein(a) as well as the cholesterol/HDL ratio were significantly higher, and HDL cholesterol lower in patients with a stenosis and extent score greater than 0, compared to patients with a stenosis or extent score of 0 (Table 4 (a) and (b)). The differences remained significant for the subgroup of asymptomatic patients (for blood pressure only a trend), whereas risk factors and lipid levels were not significantly different in symptomatic patients with stenosis and extent scores greater than 0 vs 0 (not shown). Calculating the correlation coefficients, there was a strong correlation only between age and the scores, and 
Discussion
It has been difficult to estimate precisely the prevalence of coronary artery disease in the general population, especially in asymptomatic patients: on the one hand, non-invasive tests (exercise-test, thallium-scintigraphy) cannot fully rule out coronary heart disease; on the other hand, invasive diagnostic procedures such as coronary angiography cannot be consecutively performed in an asymptomatic cohort of persons without pathological non-invasive tests or without any evidence of myocardial ischaemia. In our investigation, we achieved systematic coronary angiography in symptomatic as well as in asymptomatic patients. This was realized because our study group consisted of consecutive patients referred for invasive electrophysiological examination and intervention to treat accessory pathways, or to perform atrioventricular node modification. In this special clinical setting, routine coronary angiography seemed mandatory, so that we 
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could ascertain the coronary artery status, as regards possible peri-procedural complications, before performing the planned electrophysiological interventional procedure. In conclusion, our analysis enabled us to define the extent of coronary vessel wall alterations in a group of definitely asymptomatic as well as symptomatic subjects. This group was as near as possible representative of male and female persons aged 40 to 70 years in the general population. Concerning our analysis it must be kept in mind that the investigated study group suffers from supraventricular tachycardia.
Regarding previous reports, post-mortem analyses of asymptomatic patients who died of causes unrelated to coronary artery disease pointed to an estimated prevalence of coronary artery disease of 4·5%, 6·4% in men and 2·6% in women [5] . A higher prevalence (of 10%) of one-vessel disease has been reported from autopsies in individuals who died of non-cardiac causes [1] . 
A. Enbergs et al.
Gensini et al. [6] demonstrated an incidence of 4·5%, (6% in males vs 3·4% in females) in a group of 278 adults undergoing cardiac catheterization with the clinical diagnosis of valvular or congenital heart disease in the absence of symptoms suspicious for coronary artery disease. These patients underwent coronary angiography before necessary cardiac surgery [6] . In further studies coronary angiography was restricted to patients who were asymptomatic but presented with an abnormal ECG, exercise test or thallium scanning. In a study of 5000 asymptomatic male subjects, 30-65 years old, 86 persons (1·7%) proceeded to coronary angiography due to pathological non-invasive tests; 67 showed significant coronary artery disease, resulting in a prevalence of coronary artery disease of 1·34% in the whole study population of patients with signs of myocardial ischaemia [7] . Two further investigations including 2014 and 1390 male persons using exercise testing as a screening method for silent ischaemia reported a prevalence of 2·5% of significant coronary artery disease documented by coronary angiography [8, 9] . In another study with a relatively smaller number of patients (129 asymptomatic men), the coincidence of ST-segment depression and coronary artery calcification at fluoroscopy was highly predictive of coronary artery disease at angiography, showing a prevalence of 10% [10] In the elderly and symptomatic patients, a link between radiographically detectable coronary calcium deposits and future events of coronary heart disease seems to be likely [11] . The majority of patients with angiographically normal coronary arteries are negative for coronary calcification at electron beam computed tomography; a low risk of cardiovascular events within the next 2-5 years could be documented for these patients [11] . In the subgroup without angina, coronary calcification was identified by means of computed tomography in only 4% [11] . None of these had significant stenoses on the coronary angiogram.
Asymptomatic subjects differ from symptomatic subjects in two regards. According to the data of the Framingham study, asymptomatic subjects (particularly younger) have a relatively low risk of coronary events [12] . In consequence, there is less incentive to screen such patients. Regarding the literature, more information is available about asymptomatic postinfarction patients [13] . Nevertheless, there is some interest in the group of asymptomatic patients since data on silent myocardial ischaemia and sudden death are similar (0·5% prevalence of sudden death due to coronary artery disease in an asymptomatic population [8] ). Two decades ago, assessment in coronary angiographical studies of the sensitivity and specificity in the general population, of asymptomatic subjects without ECG signs of coronary artery disease was discussed theoretically. However, there was no consensus due to the inheritent risks of the procedure at that time [8] . Comparing the risk profile of asymptomatic persons in our study group to the male persons in the prospective cardiovascular Mü nster study (PROCAM) [14] without evidence for coronary artery disease there are no striking differences. Comparing our symptomatic patients to the male PROCAM persons with clinical evidence of coronary artery disease we find higher levels of risk factors in the PROCAM group. The risk factor levels of patients with one-to three-vessel disease (Table 3) are nearly equal to those of the PROCAM group with clinical evidence of coronary artery disease. This emphasizes that our study group does not comprise of a group of persons presenting with a totally different, highly elevated cardiovascular risk profile. It therefore may be justified to describe our study cohort as a 'nearly normal population'.
Concerning the prevalence of coronary artery disease, our analysis not only considered the extent of so-called critically stenosed vessels, but also included an evaluation of diffuse vessel wall alterations using two well established score systems. In the total group of patients, we found a prevalence of 7·3% of coronary artery disease, with at least one critical stenosis greater than 50%, 17·1% in symptomatic and 3·8% in asymptomatic persons. This underscores that in asymptomatic patients critical stenoses are rare. The extent of diffuse vessel wall alterations, as assessed by stenosis and extent scores, can be regarded as considerably low. It is worthwhile mentioning that the overall extent of coronary artery disease was low, even though this study cohort presented with a moderately elevated total cholesterol, a slightly elevated lipoprotein(a) level, a borderline ratio of total to HDL cholesterol and a considerable proportion of smokers and patients with hypertension and elevated body mass index, which is not negligible. From a clinical point of view, our data suggest that persons without clinical evidence of coronary artery disease (no history, no pathological non-invasive test) rarely prove to have significant stenoses even though they present with a moderately elevated risk profile for coronary artery disease.
In consequence, patients without clinical evidence for coronary artery disease no longer undergo routine coronary angiography in our department. Our clinical practice has been modified to the following regimen: patients referred for catheter ablation without any symptoms typical of coronary artery disease do not undergo coronary angiography. This diagnostic procedure is only recommended when non-invasive diagnostic procedures are suspicious of coronary artery disease (e.g. regional left ventricular wall abnormalities during transthoracic echocardiography, pathological thallium scintigraphy, etc.) or the patient presents with a high risk profile of cardiovascular risk factors (e.g. serum cholesterol >300 mg . dl 1 , excessive smoking, etc).
Interpreting the angiographic findings in asymptomatic patients it must be considered that the study group may differ from a representative population sample. This becomes obvious regarding the level of medical treatment within our study group: 6·9% of the patients were treated with ACE inhibitors, 3·3% with nitrates, 17·8% with calcium antagonists, 13·6% with antiplatelet agents and 3·3% of patients received lipid lowering
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agents. It is likely that this treatment level is higher than the treatment level in a representative study population.
Knowing that plaque morphology appears to be most relevant concerning cardiovascular events (myocardial infarction, ischaemic syndromes), we plan to establish a follow-up analysis of these patients to compare the angiographic features of coronary artery disease to the incidence of cardiovascular events in the long-term. It will be interesting to find out whether patients with more diffuse or patients with more focal, critical stenoses have different long-term morbidity and mortality. Since the number of patients in our study group is relatively low concerning the topic of cardiovascular events, mortality and morbidity, a separate analysis is necessary to investigate the clinical course of these patients in a further long-term follow up several years after coronary angiography prior to the ablation procedure.
Regarding well known risk factors for coronary artery disease, our data demonstrate that in patients without any critically stenosed arteries, a strong correlation between the extent of diffuse atherosclerotic vessel wall alterations and the absolute level of LDL cholesterol, HDL cholesterol and other risk factors can be confirmed. This underlines that well known risk factors already contribute to the angiographic manifestation of coronary artery disease at a stage when the person themself does not show any clinical manifestation or functional relevance of coronary artery disease.
